Furthermore, serum and synovial fluid may be involved in OA progression through the regulation of pro-inflammatory markers such as IL-1β, IL-6, IP-10, and leptin in obesity conditions [21]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.